US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 4.250
  • +0.270+6.78%
Close Dec 2 16:00 ET
  • 4.450
  • +0.200+4.71%
Pre 08:32 ET
125.84MMarket Cap-5483P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
49.96%-1M
-4,435.38%-1.52M
-163.60%-1.94M
-723.58%-3.86M
-325.04%-1.09M
-2,331.29%-2M
-33.58K
-735.74K
-292.53%-468.66K
-255.79K
Net income from continuing operations
-246.56%-5.93M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
---1.55M
---482.94K
-518.36%-854.15K
---487.1K
Operating gains losses
----
----
----
--7.49M
----
----
----
----
----
----
Other non cash items
--0
--0
--4.34M
--1.61M
--730.23K
--757.17K
----
----
----
----
Change In working capital
111.74%123.13K
-105.30%-73.84K
90.76%-23.35K
-70.47%113.84K
-90.06%23K
-794.31%-1.05M
--1.39M
---252.8K
1,957.57%385.49K
--231.31K
-Change in prepaid assets
1,186.81%10.47K
--11K
---98.1K
---713
--250
---963
--0
--0
--0
--0
-Change in payables and accrued expense
110.75%112.67K
-106.09%-84.84K
129.57%74.74K
-70.28%114.56K
-90.16%22.75K
-793.67%-1.05M
--1.39M
---252.8K
1,957.57%385.49K
--231.31K
Cash from discontinued investing activities
Operating cash flow
49.96%-1M
-4,435.38%-1.52M
-163.60%-1.94M
-723.58%-3.86M
-325.04%-1.09M
-2,331.29%-2M
---33.58K
---735.74K
-292.53%-468.66K
---255.79K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-102.36%-46.91K
185.43%132.44K
608.10%5.21M
721.05%3.86M
332.87%1.09M
2,388.86%1.99M
46.4K
736.13K
293.72%470.08K
250.88K
Net issuance payments of debt
-118.39%-132.44K
-72.86%132.44K
---101K
573.80%3.12M
684.43%1.91M
800.00%720K
--487.91K
--0
--462.39K
--243.19K
Net common stock issuance
--0
--0
483.30%5.83M
--1M
--90K
--0
---90K
--1M
--0
--0
Net other financing activities
-93.27%85.53K
--0
-96.87%-519.48K
-3,429.04%-255.97K
---911.67K
--1.27M
---351.52K
---263.87K
-93.56%7.69K
----
Cash from discontinued financing activities
Financing cash flow
-102.36%-46.91K
185.43%132.44K
608.10%5.21M
721.05%3.86M
332.87%1.09M
2,388.86%1.99M
--46.4K
--736.13K
293.72%470.08K
--250.88K
Net cash flow
Beginning cash position
12,777.91%1.88M
181,101.66%3.27M
-13.25%1.23K
--1.42K
-61.26%2.45K
67.67%14.63K
--1.81K
--1.42K
--0
--6.33K
Current changes in cash
-8,516.83%-1.05M
-10,943.90%-1.39M
843,478.09%3.27M
-113.25%-188
75.14%-1.22K
-408.43%-12.18K
--12.82K
--388
--1.42K
---4.91K
End cash Position
33,939.07%834.64K
12,777.91%1.88M
181,101.66%3.27M
-13.25%1.23K
-13.25%1.23K
-61.26%2.45K
--14.63K
--1.81K
--1.42K
--1.42K
Free cash flow
49.96%-1M
-4,435.38%-1.52M
-163.60%-1.94M
-723.58%-3.86M
-325.04%-1.09M
-2,331.29%-2M
---33.58K
---735.74K
-292.53%-468.66K
---255.79K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 49.96%-1M-4,435.38%-1.52M-163.60%-1.94M-723.58%-3.86M-325.04%-1.09M-2,331.29%-2M-33.58K-735.74K-292.53%-468.66K-255.79K
Net income from continuing operations -246.56%-5.93M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M---1.55M---482.94K-518.36%-854.15K---487.1K
Operating gains losses --------------7.49M------------------------
Other non cash items --0--0--4.34M--1.61M--730.23K--757.17K----------------
Change In working capital 111.74%123.13K-105.30%-73.84K90.76%-23.35K-70.47%113.84K-90.06%23K-794.31%-1.05M--1.39M---252.8K1,957.57%385.49K--231.31K
-Change in prepaid assets 1,186.81%10.47K--11K---98.1K---713--250---963--0--0--0--0
-Change in payables and accrued expense 110.75%112.67K-106.09%-84.84K129.57%74.74K-70.28%114.56K-90.16%22.75K-793.67%-1.05M--1.39M---252.8K1,957.57%385.49K--231.31K
Cash from discontinued investing activities
Operating cash flow 49.96%-1M-4,435.38%-1.52M-163.60%-1.94M-723.58%-3.86M-325.04%-1.09M-2,331.29%-2M---33.58K---735.74K-292.53%-468.66K---255.79K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -102.36%-46.91K185.43%132.44K608.10%5.21M721.05%3.86M332.87%1.09M2,388.86%1.99M46.4K736.13K293.72%470.08K250.88K
Net issuance payments of debt -118.39%-132.44K-72.86%132.44K---101K573.80%3.12M684.43%1.91M800.00%720K--487.91K--0--462.39K--243.19K
Net common stock issuance --0--0483.30%5.83M--1M--90K--0---90K--1M--0--0
Net other financing activities -93.27%85.53K--0-96.87%-519.48K-3,429.04%-255.97K---911.67K--1.27M---351.52K---263.87K-93.56%7.69K----
Cash from discontinued financing activities
Financing cash flow -102.36%-46.91K185.43%132.44K608.10%5.21M721.05%3.86M332.87%1.09M2,388.86%1.99M--46.4K--736.13K293.72%470.08K--250.88K
Net cash flow
Beginning cash position 12,777.91%1.88M181,101.66%3.27M-13.25%1.23K--1.42K-61.26%2.45K67.67%14.63K--1.81K--1.42K--0--6.33K
Current changes in cash -8,516.83%-1.05M-10,943.90%-1.39M843,478.09%3.27M-113.25%-18875.14%-1.22K-408.43%-12.18K--12.82K--388--1.42K---4.91K
End cash Position 33,939.07%834.64K12,777.91%1.88M181,101.66%3.27M-13.25%1.23K-13.25%1.23K-61.26%2.45K--14.63K--1.81K--1.42K--1.42K
Free cash flow 49.96%-1M-4,435.38%-1.52M-163.60%-1.94M-723.58%-3.86M-325.04%-1.09M-2,331.29%-2M---33.58K---735.74K-292.53%-468.66K---255.79K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data